Phase 3 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with cervical cancer (confirmed by a tissue sample/biopsy) that is at stage IIIC or higher.
- You are between 20 and 85 years old.
- You are fairly active and able to carry out daily activities with little to no limitation (confirm with trial site).
- Your doctor has determined that you are suitable for a type of radiation treatment that covers a wider area of the body, called extended-field radiotherapy.
- You may have received up to 6 weeks or 2 rounds of initial chemotherapy using the drugs paclitaxel and carboplatin before joining.
- During radiation treatment, you may receive either radiation alone, or one chemotherapy drug at a time (weekly cisplatin or carboplatin), but no other cancer-fighting drugs at the same time.
- You may receive additional chemotherapy or immunotherapy after radiation treatment is completed.
Who may not be able to join:
- You have previously had radiation therapy to your pelvis or abdomen.
- Your cancer has spread to distant parts of the body, or you have had another active cancer in the past 5 years (skin cancers that are not melanoma are generally excepted — confirm with trial site).
- You have serious ongoing health conditions, such as uncontrolled diabetes, heart disease, or autoimmune disorders, that could interfere with treatment or taking part in the study.
- You are currently pregnant or breastfeeding.
- You have psychiatric or personal/social circumstances that might make it difficult to follow the study's requirements or attend follow-up visits.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 886-2-23123456
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Lymphocyte Counts; Immune Cell Subsets
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.